What is the current valuation of the genetic testing market in Italy as of 2024?

The overall market valuation was $332.5 Million in 2024. Read More

What is the projected market valuation for the genetic testing market in Italy by 2035?

The projected valuation for 2035 is $2216.0 Million. Read More

What is the expected CAGR for the genetic testing market in Italy during the forecast period 2025 - 2035?

The expected CAGR for the market during this period is 18.82%. Read More

Which application segment had the highest valuation in 2024 within the genetic testing market?

Diagnostic Testing had the highest valuation at $80.0 Million in 2024. Read More

What is the projected valuation for prenatal testing in the genetic testing market by 2035?

The projected valuation for prenatal testing is $442.0 Million by 2035. Read More

Which type of genetic testing is expected to see significant growth in the coming years?

Panel Tests, with a projected valuation of $600.0 Million by 2035, are expected to see significant growth. Read More

What are the key players currently leading the genetic testing market in Italy?

Key players include Illumina, Thermo Fisher Scientific, Myriad Genetics, and 23andMe. Read More

What service type generated the highest revenue in the genetic testing market in 2024?

Diagnostic Services generated the highest revenue at $150.0 Million in 2024. Read More

Which end user segment is projected to have the highest valuation by 2035?

Homecare Settings are projected to have the highest valuation at $894.0 Million by 2035. Read More

How does the market for carrier testing compare to that of newborn screening in 2024?

Carrier Testing was valued at $40.0 Million, while Newborn Screening was valued at $50.0 Million in 2024. Read More

Italy Genetic Testing Market

ID: MRFR/LS/43269-HCR

200 Pages

Satyendra Maurya

Last Updated: April 06, 2026

Italy Genetic Testing Market Research Report By Type (Molecular Genetic Tests/ DNA Tests, Chromosomal Genetic Tests, Biochemical Genetic Tests, Others), By Type (Prescribed Genetic Testing, Direct-to-Consumer Genetic Testing), and By Application (Reproductive Health, Cancer Screening Ancestry, Predictive and Pre-Symptomatic Testing, Others) - Growth & Industry Forecast 2025 To 2035

Italy Genetic Testing Market Infographic

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Life Sciences, BY Application (USD Million)
  1. 4.1.1 Prenatal Testing
  2. 4.1.2 Newborn Screening
  3. 4.1.3 Carrier Testing
  4. 4.1.4 Diagnostic Testing
  5. 4.1.5 Predictive Testing
2. 4.2 Life Sciences, BY Type (USD Million)
  1. 4.2.1 Single Gene Tests
  2. 4.2.2 Panel Tests
  3. 4.2.3 Whole Exome Sequencing
  4. 4.2.4 Whole Genome Sequencing
  5. 4.2.5 Non-Invasive Prenatal Testing
3. 4.3 Life Sciences, BY Service Type (USD Million)
  1. 4.3.1 Laboratory Services
  2. 4.3.2 Diagnostic Services
  3. 4.3.3 Consultation Services
4. 4.4 Life Sciences, BY End User (USD Million)
  1. 4.4.1 Hospitals
  2. 4.4.2 Clinical Laboratories
  3. 4.4.3 Research Institutions
  4. 4.4.4 Homecare Settings
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Life Sciences
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Life Sciences
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Illumina (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Thermo Fisher Scientific (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Myriad Genetics (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 23andMe (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Genomic Health (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Fulgent Genetics (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Natera (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Invitae (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 Genoa Healthcare (US)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 ITALY MARKET ANALYSIS BY APPLICATION
3. 6.3 ITALY MARKET ANALYSIS BY TYPE
4. 6.4 ITALY MARKET ANALYSIS BY SERVICE TYPE
5. 6.5 ITALY MARKET ANALYSIS BY END USER
6. 6.6 KEY BUYING CRITERIA OF LIFE SCIENCES
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF LIFE SCIENCES
9. 6.9 DRIVERS IMPACT ANALYSIS: LIFE SCIENCES
10. 6.10 RESTRAINTS IMPACT ANALYSIS: LIFE SCIENCES
11. 6.11 SUPPLY / VALUE CHAIN: LIFE SCIENCES
12. 6.12 LIFE SCIENCES, BY APPLICATION, 2024 (% SHARE)
13. 6.13 LIFE SCIENCES, BY APPLICATION, 2024 TO 2035 (USD Million)
14. 6.14 LIFE SCIENCES, BY TYPE, 2024 (% SHARE)
15. 6.15 LIFE SCIENCES, BY TYPE, 2024 TO 2035 (USD Million)
16. 6.16 LIFE SCIENCES, BY SERVICE TYPE, 2024 (% SHARE)
17. 6.17 LIFE SCIENCES, BY SERVICE TYPE, 2024 TO 2035 (USD Million)
18. 6.18 LIFE SCIENCES, BY END USER, 2024 (% SHARE)
19. 6.19 LIFE SCIENCES, BY END USER, 2024 TO 2035 (USD Million)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 Italy MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.2.2 BY TYPE, 2025-2035 (USD Million)
  3. 7.2.3 BY SERVICE TYPE, 2025-2035 (USD Million)
  4. 7.2.4 BY END USER, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

Italy Life Sciences Market Segmentation

Life Sciences By Application (USD Million, 2025-2035)

Prenatal Testing
Newborn Screening
Carrier Testing
Diagnostic Testing
Predictive Testing

Life Sciences By Type (USD Million, 2025-2035)

Single Gene Tests
Panel Tests
Whole Exome Sequencing
Whole Genome Sequencing
Non-Invasive Prenatal Testing

Life Sciences By Service Type (USD Million, 2025-2035)

Laboratory Services
Diagnostic Services
Consultation Services

Life Sciences By End User (USD Million, 2025-2035)

Hospitals
Clinical Laboratories
Research Institutions
Homecare Settings

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”